Indiana University/Melvin and Bren Simon Cancer Center — Indianapolis, Indiana

Public research footprint of Indiana University/Melvin and Bren Simon Cancer Center, compiled from the ClinicalTrials.gov public registry.

485

Registered studies

169

Active

Recruiting now

234

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Lung Non-Small Cell Carcinoma · Metastatic Non-Cutaneous Melanoma

Recently updated registry entries

NCT03258554 — Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally… (Completed)
NCT06317649 — Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid… (Recruiting)
NCT05987241 — Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Indiana University/Melvin and Bren Simon Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.